Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Divestments (2018)

Pharma-Bio Serv (PBSV) has disclosed Divestments for 1 consecutive years, with $2.0 million as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Divestments changed N/A year-over-year to $2.0 million, compared with a TTM value of $2.0 million through Jul 2019, changed N/A, and an annual FY2018 reading of $2.0 million, up 606.67% over the prior year.
  • Divestments was $2.0 million for Q4 2018 at Pharma-Bio Serv.
  • Across five years, Divestments topped out at $2.0 million in Q4 2018 and bottomed at $2.0 million in Q4 2018.